This is the authors' abstract. We don't add key points for this paper.
glycan. Effective bNAbs can therefore be raised against HIV-1 Env's silent face, suggesting their potential for HIV-1 prevention, therapy, and vaccine development.
No takes yet. Share an insight, caveat, or question.
Schoofs et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from Immunity